تداخل‌های دارویی
Ceritinib + Octreotide
شدت: شدید
Ceritinib and Octreotide: major interaction.
آخرین به‌روزرسانی
ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.
محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.
خلاصه
Ceritinib prolongs the QT interval and can cause bradycardia, and octreotide has similar effects on heart rate and conduction. Together they may increase the risk of torsades de pointes.
معنای این تداخل به زبان ساده
Ceritinib and Octreotide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Ceritinib belongs to Oncology; Octreotide belongs to Endocrine.
چرا رخ می‌دهد
Additive QTc prolongation and bradycardia.
اقدام لازم
Avoid if possible; otherwise monitor ECG and electrolytes regularly and correct potassium and magnesium, reducing the ceritinib dose or interrupting it if QTc becomes markedly prolonged.
از داروساز چه بپرسید
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
ویژه اعضای Pro+
باز کردن کل صفحه
یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Ceritinib و Octreotide، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Pro+ را ۷ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.
تداخلات دیگر Octreotide
تداخلات دیگر Ceritinib
- Ceritinib + Cisapride منع مصرف
- Ceritinib + Eletriptan منع مصرف
- Ceritinib + Flibanserin منع مصرف
- Ceritinib + Pimozide منع مصرف
- Ceritinib + Thioridazine منع مصرف
- Ceritinib + Tolvaptan منع مصرف
پرسش‌های متداول
Can I take Ceritinib with Octreotide?
MediHelp rates the interaction as major. Ceritinib and Octreotide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Ceritinib prolongs the QT interval and can cause bradycardia, and octreotide has similar effects on heart rate and conduction. Together they may increase the risk of torsades de pointes.
How serious is the interaction between Ceritinib and Octreotide?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid if possible; otherwise monitor ECG and electrolytes regularly and correct potassium and magnesium, reducing the ceritinib dose or interrupting it if QTc becomes markedly prolonged.
What other medicines interact with Octreotide?
MediHelp also lists interactions of Octreotide with, for example, Adagrasib, Amisulpride, Arsenic trioxide. The full list is on the Octreotide page.
تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp
مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.
